Published in PLoS One on September 23, 2009
Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260
The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol (2011) 3.13
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Nat Nanotechnol (2015) 1.04
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection. Viruses (2012) 0.93
Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov (2016) 0.91
Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function. Am J Pathol (2012) 0.90
ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am J Pathol (2010) 0.90
A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine (2012) 0.89
Immunogenic properties of archaeal species found in bioaerosols. PLoS One (2011) 0.88
Pulmonary dendritic cells: thinking globally, acting locally. J Exp Med (2010) 0.86
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice. J Virol (2013) 0.85
Tertiary Lymphoid Organs in Cancer Tissues. Front Immunol (2016) 0.84
Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses. Lymphat Res Biol (2013) 0.84
B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection. J Immunol (2014) 0.83
CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. Eur J Immunol (2014) 0.82
Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine. PLoS One (2012) 0.80
Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Eur J Immunol (2014) 0.80
Development of virus-like particles for diagnostic and prophylactic biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.80
Virus-based nanoparticles as platform technologies for modern vaccines. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.80
Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link? Am J Respir Cell Mol Biol (2012) 0.79
Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM). J Virol (2015) 0.78
Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung. Nanomedicine (Lond) (2014) 0.78
Neonatal irradiation sensitizes mice to delayed pulmonary challenge. Radiat Res (2012) 0.78
Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung. Front Immunol (2016) 0.77
Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together. Front Immunol (2016) 0.76
Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense. Cytokine (2016) 0.76
Tertiary lymphoid structures target the antitumor immune response to lung cancer. Am J Respir Crit Care Med (2014) 0.75
The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation. Immunology (2016) 0.75
Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology. Adv Virus Res (2016) 0.75
Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection. Front Immunol (2016) 0.75
Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction. Semin Immunol (2011) 0.75
Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1(-/-) mice. J Leukoc Biol (2017) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med (2004) 5.22
Crystal structure of a small heat-shock protein. Nature (1998) 4.07
Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest (2006) 2.56
Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 2.18
Development of secondary lymphoid organs. Annu Rev Immunol (2008) 2.10
Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol (2003) 2.05
Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity (2006) 1.95
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol (2001) 1.63
Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett (2008) 1.58
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines (2004) 1.38
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med (2003) 1.35
Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem Biol (2006) 1.23
Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia. Infect Immun (2007) 1.15
Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. J Immunol (2005) 1.02
Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. Vaccine (2006) 0.97
Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation. Am J Pathol (1999) 0.86
Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice. Vaccine (2008) 0.82
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol (2007) 10.71
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med (2004) 5.22
Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol (2010) 3.56
Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33
CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med (2002) 3.28
Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med (2008) 3.15
The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol (2011) 3.13
Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med (2010) 3.02
Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity (2012) 2.87
Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity (2009) 2.68
Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest (2006) 2.56
Viruses: making friends with old foes. Science (2006) 2.55
Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol (2010) 2.27
Structure of an archaeal virus capsid protein reveals a common ancestry to eukaryotic and bacterial viruses. Proc Natl Acad Sci U S A (2005) 2.26
Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med (2004) 2.23
Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity (2004) 2.23
Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 2.18
The structure of a thermophilic archaeal virus shows a double-stranded DNA viral capsid type that spans all domains of life. Proc Natl Acad Sci U S A (2004) 2.13
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol (2008) 2.10
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med (2010) 2.10
Acute lung injury in critical neurological illness. Crit Care Med (2012) 2.09
The Child Health Epidemiology Reference Group reviews of the effectiveness of interventions to reduce maternal, neonatal and child mortality. Int J Epidemiol (2010) 2.03
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother (2006) 2.00
Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity (2006) 1.95
CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A (2003) 1.89
Assembly of viral metagenomes from yellowstone hot springs. Appl Environ Microbiol (2008) 1.86
B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol (2006) 1.86
Metagenomes from high-temperature chemotrophic systems reveal geochemical controls on microbial community structure and function. PLoS One (2010) 1.85
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res (2009) 1.82
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res (2013) 1.79
CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol (2005) 1.77
Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol (2011) 1.74
Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med (2011) 1.72
Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol (2009) 1.71
Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc (2006) 1.70
Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J Exp Med (2005) 1.59
Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun (2005) 1.56
Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci U S A (2007) 1.56
CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. J Clin Invest (2013) 1.55
Comparative genomic analysis of hyperthermophilic archaeal Fuselloviridae viruses. J Virol (2004) 1.54
Community health workers providing government community case management for child survival in sub-Saharan Africa: who are they and what are they expected to do? Am J Trop Med Hyg (2012) 1.54
A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica (2005) 1.50
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
Characterization of the archaeal thermophile Sulfolobus turreted icosahedral virus validates an evolutionary link among double-stranded DNA viruses from all domains of life. J Virol (2006) 1.44
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine (2010) 1.43
Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat Immunol (2012) 1.40
The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med (2002) 1.40
IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol (2011) 1.40
In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol (2009) 1.38
Transcriptome analysis of infection of the archaeon Sulfolobus solfataricus with Sulfolobus turreted icosahedral virus. J Virol (2008) 1.37
Profiling early lung immune responses in the mouse model of tuberculosis. PLoS One (2011) 1.36
Particle assembly and ultrastructural features associated with replication of the lytic archaeal virus sulfolobus turreted icosahedral virus. J Virol (2009) 1.36
B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms. J Immunol (2008) 1.35
Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol (2011) 1.35
Setting research priorities to reduce mortality and morbidity of childhood diarrhoeal disease in the next 15 years. PLoS Med (2013) 1.34
Identification of novel positive-strand RNA viruses by metagenomic analysis of archaea-dominated Yellowstone hot springs. J Virol (2012) 1.33
Plant viruses as biotemplates for materials and their use in nanotechnology. Annu Rev Phytopathol (2008) 1.32
Structural and functional studies of archaeal viruses. J Biol Chem (2009) 1.32
Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine (2005) 1.31
Simultaneous detection of EGFP and cell surface markers by fluorescence microscopy in lymphoid tissues. J Histochem Cytochem (2003) 1.30
Adaptive immunity and adipose tissue biology. Trends Immunol (2010) 1.29
Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol (2002) 1.29
Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol (2007) 1.29
Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody. J Immunol (2003) 1.29
Viral capsids as MRI contrast agents. Magn Reson Med (2007) 1.28
Human ferritin cages for imaging vascular macrophages. Biomaterials (2010) 1.28
Setting implementation research priorities to reduce preterm births and stillbirths at the community level. PLoS Med (2011) 1.28
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine (2007) 1.27
CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J Exp Med (2003) 1.27
Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths. Lancet (2013) 1.27
An archaeal antioxidant: characterization of a Dps-like protein from Sulfolobus solfataricus. Proc Natl Acad Sci U S A (2005) 1.24
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 1.24
Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem Biol (2006) 1.23
Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. Nat Chem (2012) 1.23
A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med (2008) 1.23
Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13. J Immunol (2004) 1.22
Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue. J Immunol (2005) 1.20
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob Agents Chemother (2005) 1.20
Virus movement maintains local virus population diversity. Proc Natl Acad Sci U S A (2007) 1.16
Structure of A197 from Sulfolobus turreted icosahedral virus: a crenarchaeal viral glycosyltransferase exhibiting the GT-A fold. J Virol (2006) 1.15
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol (2009) 1.15
Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. Langmuir (2007) 1.14
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Res (2010) 1.13
The ferritin superfamily: Supramolecular templates for materials synthesis. Biochim Biophys Acta (2009) 1.12
Respiratory syncytial virus infections: recent prospects for control. Antiviral Res (2006) 1.10
Implementation of p22 viral capsids as nanoplatforms. Biomacromolecules (2010) 1.09
Synthesis of a cross-linked branched polymer network in the interior of a protein cage. J Am Chem Soc (2009) 1.09
Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. ACS Nano (2012) 1.09
The alcohol hangover research group consensus statement on best practice in alcohol hangover research. Curr Drug Abuse Rev (2010) 1.09
Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett (2009) 1.08